Prefilled Syringes Market

Prefilled Syringes Market Size (2022 to 2027)

As per our report, the global prefilled syringes market size is estimated to be USD 4.42 billion in 2022 and is expected to grow at a CAGR of 10.7%, to reach USD 7.34 billion by 2027.

A prefilled syringe is a single-dose vaccine packet that has been fitted with a needle by the manufacturer. Metal or glass syringes were once popular, but there is now a trend toward plastic and disposable syringes, protecting the needle and preventing it from being reused (prefilled disposable systems). For both patients and physicians, the prefilled syringes make injections easy, accurate, and safe. As the pharmaceutical industry seeks new and more convenient drug delivery methods, pre-filled syringes have emerged as one of the fastest-growing options for unit-dose medication. In addition to vaccines, blood stimulants, and medicinal proteins, pre-filled syringes have been used in various therapeutic fields. According to the Autoimmune Research Foundation, the spread of chronic inflammatory diseases is due to antibiotic abuse, vitamin supplementation, the presence of environmental factors that suppress immunity, new vectors sharing pathogens (including blood donations), and forced large Caused by the widespread use of large-scale vaccination.

Impact of COVID-19 on the global prefilled syringes market:

The COVID-19 impact has positively affected the prefilled syringes market. The novel Coronavirus's impact, especially on pharmaceutical packaging, is projected to be more striking because of the production of the vaccines for the coronavirus. There is a surge in demand for the prefilled syringes over other needles to minimize the risk of needlestick injuries. Hence, intending to incline the production of the COVID-19 vaccine, the manufacturers are ready to increase production efficiency. For instance, the United States government agreed to $138 million with the manufacturers to escalate the production of 100 million more prefilled syringes for the Coronavirus vaccines by the end of 2020 and more than 500 million by 2021. An escalation in clinical trials for coronaviruses has shown an outcome in the large production of different drugs. The shares of this market to grow at a higher rate in the foreseen years.

MARKET DRIVERS:

The global prefilled syringes market growth is majorly driven by the increased incidence of chronic illness, increased demand for self-medication, and the growing elderly population worldwide.

The development of technologically advanced prefilled syringes and the growing demand for self-injected devices dominate the prefilled syringes market. Many patients affected by chronic diseases are benefited from prefilled syringes as there is a need for continuous medication in chronic diseases, which is driving the market. 

The full availability and increasing use of single-cavity prefilled syringes are key factors driving the growth of the global prefilled syringes market. Due to lifestyle changes and the lack of preventive care opportunities, the healthcare industry has witnessed chronic diseases such as cardiovascular, cancer, respiratory, and diabetes, especially in developing countries. It is merely to boost up the market demand for prefilled syringes.

The health care industries have witnessed the prevalence of chronic diseases such as diabetes, cardiovascular and cancer in developing countries. It has boosted the market demand for prefilled syringes. The devices like pen injection are one of the significant selling products in prefilled syringes. 

MARKET RESTRAINTS:

However, certain complexities associated, such as drug reaction with primary packaging, may affect the prefilled syringes market growth to a certain extent. The response with plastic also affects the quality of the drugs, which is hampering the market growth.

REPORT COVERAGE:

This research report on the global prefilled syringes market has been segmented and sub-segmented based on the material, type, design, application, distribution channel, and region.

Prefilled Syringes Market - By Material:

• Glass prefilled syringes
• Plastic prefilled syringes

Based on the material, the glass prefilled syringes segment is estimated to account for the largest share in the global market. An increasing number of people suffering from chronic diseases is a major factor for this segment to grow eventually. Increasing support from government organizations is leveling up the demand of the market.

The plastic market segment will likely reach a CAGR of more than 12% over the estimated forecast period. The plastic material is designed with a break and is flexible compared to glass. The polymers exhibit minimal drug absorption with reduced surface reactivity and excellent compatibility with pH change. Manufacturers have developed cyclic olefinic copolymers, which offer high heat resistance and better visibility. The above advantages of plastic are contributing to the growth of the segment during the forecast period.

Prefilled Syringes Market - By Type:

• Conventional
• Safety

Based on the type, the safety prefilled syringes segment is awaited to showcase a strong growth rate over the period. Growing disposable income and the rising prevalence of innovative products in healthcare are boosting up the market demand. The safety prefilled syringes segment is to have the fastest growth rate in the forecast period.

Prefilled Syringes Market - By Design:

• Single-Chamber
• Dual-Chamber

Based on the design, in 2019, the Single chamber held the leading position in the market and expected to continue the same growth trends during the forecast period. Single-chamber prefilled syringes protect patients and clinicians from needle stick injuries that will augment the demand. The simple storage and easy usage of a single chamber design will help the market to grow.

The dual-chamber segment will grow around 12% CAGR in the following year. Dual-chamber design allows solvents and ingredients to be separately filled. As the dual chamber design gives excellent storage and delivery of the medication, its demand will rise in the coming years.

Prefilled Syringes Market - By Application:

• Vaccines
• Monoclonal Antibodies

Based on the application, the monoclonal antibodies segment is witnessed to lead the market growth during the forecast period. The surge in awareness regarding the developments in the syringes accelerates the market demand. The rising number of hospitals is another factor propelling the growth rate of the market.

Prefilled Syringes Market - By Distribution Channel:

• Hospitals
• Ambulatory Surgical Centers
• Mail-Order Pharmacies

The hospital segment is witnessed to lead the prefilled syringes market with a huge revenue share based on the distribution channel. Factors like the rising patient population suffering from chronic diseases and increasing health disorders requiring long-term treatment are mounting the market growth. Growing cancer and diabetic diseases in patients are likely to create huge demand for market growth. The ambulatory surgical centers segment is expected to have quick growth in the market during the forecast period.

Prefilled Syringes Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Regionally, the North American market is dominating the global prefilled syringes market is estimated to be growing at a CAGR of 10% during the forecast period. Due to the increase in the prevalence of diabetes and autoimmune diseases, the aging population vulnerable to chronic diseases further supports the increase in incidence. Medicines and biologics approved for treating these diseases should be given in prefilled syringes, contributing to market development in this region.

The Asia-Pacific prefilled syringe market was worth more than the U.S. $ 900 million in 2018 and will witness significant growth during the forecast period. India and China have vast pools of diabetic patients, and many are still undiagnosed. Sedentary lifestyles and unhealthy eating habits can be associated with the increasing incidence of autoimmune and chronic diseases. As a result, the unsatisfactory demand for superior drug delivery systems is widespread in the region. Besides, the increase in disposable income in the area and the development of health infrastructure will accelerate prefilled syringes during the forecast period.

KEY MARKET PARTICIPANTS:

Some of the prominent companies operating in the global prefilled syringes market profiled in the report are Becton, Dickinson, and Company (U.S.), Gerresheimer AG (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Ompi (Italy), Catalent, Inc. (U.S.), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan) and MedPro Inc. (U.S.).

RECENT MARKET HAPPENINGS:

• In June 2019, Fresenius Kabi introduced the neostigmine methyl sulfate infusion, USP Simplist prefilled syringe in the United States. Expanding the product portfolio to a new geographic area will allow the company to capture a larger market share and survive competition in the industry.
• In September 2018, Novartis announced its FDA approval for a prefilled syringe prescription with Xolair. It is the medicine used for signs of chronic idiopathic urticaria and asthma. Products approved by the FDA will help the company to have a competitive advantage.